v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net increase (decrease) in net assets resulting from operations $ (37,236,966) $ (8,389,211)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:    
Net realized (gains)/losses on investments 10,674,426 5,894,493
Net change in unrealized (gains)/losses on investments 37,599,190 15,407,869
Net accretion of discount on investments (679,281) (598,188)
Payment-in-kind interest and other income (519,978) (507,850)
Purchases of short-term investments (107,667,662) (127,649,840)
Purchases of portfolio investments (109,362,638) (104,323,107)
Proceeds from sale of short-term investments 139,020,040 140,223,941
Proceeds from sale of portfolio investments 79,939,687 144,369,364
Amortization of deferred financing cost 440,084 424,712
Increase/(decrease) in operating assets and liabilities:    
(Increase)/decrease in receivable for sales of investments 2,283,191 (6,363,093)
(Increase)/decrease in interest and dividends receivable 192,323 1,509,133
(Increase)/decrease in due from investment adviser 0 (214,725)
(Increase)/decrease in receivable for paydowns of investments 64,420 501,065
(Increase)/decrease in prepaid expenses and other assets (21,330) (30,014)
Increase/(decrease) in interest payable on credit facilities 1,106,715 (428,607)
Increase/(decrease) in payable for investments purchased 13,199,812 (12,631,927)
Increase/(decrease) in management fees payable (196,243) (80,123)
Increase/(decrease) in incentive fee payable (290,383) (306,426)
Increase/(decrease) in accrued other general and administrative expenses 507,307 (394,115)
Net cash provided by (used in) operating activities 29,052,714 46,413,351
Cash Flows from Financing Activities:    
Borrowings on the credit facilities 0 26,600,000
Payments on the credit facilities (15,750,000) (56,300,000)
Borrowings on the notes 0 0
Payments of debt issuance costs 0 0
Distributions paid in cash (13,442,214) (15,649,925)
Purchase of common shares for dividend reinvestment plan 0 514,649
Repurchase of common shares (1,588,747) (1,472,064)
Net cash provided by (used in) financing activities (30,780,961) (46,307,340)
Net increase/(decrease) in cash and cash equivalents (1,728,247) 106,011
Cash and cash equivalents, beginning of period 3,217,449 2,766,409
Cash and cash equivalents, end of period 1,489,202 2,872,420
Supplemental and Non-Cash Information:    
Interest paid during the period 9,476,102 13,398,364
Distributions declared during the period 11,514,701 12,691,089
Distributions payable $ 11,514,701 $ 12,691,089